Early-line immunotherapy in multiple myeloma: reshaping the treatment paradigm
Multiple myeloma (MM) has traditionally been considered to be incurable, despite increasingly effective induction, transplantation, and maintenance strategies. Chimeric antigen receptor (CAR) T-cell therapies and T-cell–redirecting bispecific antibodies have produced deep and durable responses in heavily pretreated dis...